TRULICITY

•Dulaglutide can cause an increased risk of thyroid cancer s depending on the dose. So, caution is needed in patients with high risk of thyroid cancer. • Patients should inform the symptoms of thyroid cancer like swelling in the neck, difficulty swallowing, difficulty breathing(dyspnea), changes in the voice. Regular monitoring of serum calcitonin and thyroid ultrasound is recommended. • Dulaglutide can cause hypoglycemia (very low blood glucose) when used with other drugs like sulfonylurea or insulin. The dose of the sulfonylurea or insulin should be reduced in such case to decrease the risk of hypoglycemia • In case of an allergic reaction, treat promptly until signs and symptoms resolve. • Monitor kidney functions in patients with kidney disorders reporting severe gastric related side effects.